Connexin43 drives mitochondrial biogenesis and organelle stress in BRAF-mutant melanoma cells
Year: 2026
Type: preprint
Abstract: Metabolic flexibility helps cancer cells survive targeted therapy, and BRAF-mutant melanoma rewires mitochondrial metabolism in response to BRAF/MEK inhibitors (BRAF/MEKi). We previously showed that connexin43 (Cx43) acts as a tumour suppressor in BRAF-mutant melanoma and enhances the response to BRAF/MEKi. Here, we investigated whether mitochondrial remodelling contributes to these effects. Cx43 upregulation promoted mitochondrial biogenesis including selective increase of CI and CV, enhanced oxidative phosphorylation (OXPHOS), and increased reactive oxygen species (ROS) production, alongside DRP1-associated mitochondrial fragmentation. Despite enhanced mitochondrial biogenesis and OXPHOS, Cx43 upregulation was associated with respiratory chain remodelling, characterised by loss of complex IV, increased ER and mitochondrial stress, and enhanced mTORC1-associated signalling. These changes were accompanied by an adaptive unfolded protein response that did not engage the pro-apoptotic ATF4-CHOP axis. Notably, BRAF/MEK inhibition largely attenuated the mitochondrial biogenesis phenotype and most of the stress markers associated with Cx43 upregulation, while promoting mitochondrial network elongation and markedly increasing mitochondrial ROS. Despite this impact, Cx43-expressing tumour cells retained higher membrane potential, ROS levels and survival under glucose-limiting conditions. Collectively, these findings reveal a dissociation between the mitochondrial effects of Cx43 and its enhancement of the response to BRAF/MEKi, highlighting the complexity of Cx43-mediated metabolic regulation in BRAF-mutant melanoma. By distinguishing mitochondrial remodelling from therapeutic sensitisation, this study provides new insights into the response to BRAF/MEK inhibition and highlights mTORC1-associated signalling and mitochondrial oxidative stress as potential therapeutic vulnerabilities for further investigation.
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: connexin 43, BRAF-mutant melanoma, mitochondrial biogenesis, mitochondrial fragmentation, Drp1, oxidative phosphorylation, reactive oxygen species, mitochondrial stress, endoplasmic reticulum stress, mTORC1 signaling, unfolded protein response, BRAF/MEK inhibitors, targeted therapy resistance, mitochondrial metabolism, glucose limitation, tumour suppressor
Open Access status: green
OpenAlex ID: W7236562498
